Cycle Control Assessment of a Combined Oral Contraceptive Containing Estetrol and a Progestin P1 or P2

PHASE2CompletedINTERVENTIONAL
Enrollment

396

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Contraception
Interventions
DRUG

estetrol, P 1 and placebo tablets

"6 treatment cycles each consisting of 28 days of oral administration as follows:~* Days 1-24: one estetrol tablet and one P1 tablet per day~* Days 25-28: two placebo tablets per day"

DRUG

estetrol, P2 and placebo tablets

"6 treatment cycles each consisting of 28 days of oral administration as follows:~* Days 1-24: one estetrol tablet and one P2 tablet per day~* Days 25-28: two placebo tablets per day"

DRUG

Estradiol valerate, dienogest and placebo tablets

"6 treatment cycles each consisting of 28 days of oral administration as follows:~* Days 1-26: one tablet of Estradiol valerate/dienogest per day~* Days 26-28: one placebo tablet per day"

Trial Locations (10)

Unknown

Mehiläinen Helsinki, Helsinki

Väestöliitto Helsinki, Helsinki

YTHS Jyvaskyla, Jyväskylä

Laboratorio Simpanen, Kuopio

Terveystalo Kuopio, Kuopio

YTHS Kuopio, Kuopio

Väestöliitto Oulu, Oulu

Tampereen Lääkärikeskus Oy, Tampere

YTHS Tampere, Tampere

Väestöliitto Turku, Turku

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Estetra

INDUSTRY